1	1	Vaccine	vaccine	NN	3	compound	0	7	_	_
1	2	product	product	NN	3	compound	8	15	_	_
1	3	leaflets	leaflet	NNS	6	nsubj	16	24	_	_
1	4	will	will	MD	6	aux	25	29	_	_
1	5	usually	usually	RB	6	advmod	30	37	_	_
1	6	contain	contain	VB	0	ROOT	38	45	_	_
1	7	a	a	DT	9	det	46	47	_	_
1	8	detailed	detailed	JJ	9	amod	48	56	_	_
1	9	list	list	NN	6	dobj	57	61	_	_
1	10	of	of	IN	11	case	62	64	_	_
1	11	‘	‘	NN	9	nmod	65	66	_	_
1	12	undesirable	undesirable	JJ	13	amod	66	77	_	_
1	13	effects	effect	NNS	14	nsubj	78	85	_	_
1	14	’	’	VBP	9	acl:relcl	85	86	_	_
1	15	,	,	,	6	punct	86	87	_	_
1	16	or	or	CC	6	cc	88	90	_	_
1	17	they	they	PRP	19	nsubj	91	95	_	_
1	18	may	may	MD	19	aux	96	99	_	_
1	19	refer	refer	VB	6	conj	100	105	_	_
1	20	to	to	TO	23	case	106	108	_	_
1	21	‘	‘	CD	23	nummod	109	110	_	_
1	22	adverse	adverse	JJ	23	amod	110	117	_	_
1	23	reactions	reaction	NNS	19	nmod	118	127	_	_
1	24	reported	report	VBN	23	acl	128	136	_	_
1	25	in	in	IN	27	case	137	139	_	_
1	26	clinical	clinical	JJ	27	amod	140	148	_	_
1	27	studies	study	NNS	24	nmod	149	156	_	_
1	28	or	or	CC	27	cc	157	159	_	_
1	29	from	from	IN	33	case	160	164	_	_
1	30	the	the	DT	33	det	165	168	_	_
1	31	postmarketing	postmarketing	JJ	33	amod	169	182	_	_
1	32	experience	experience	NN	33	compound	183	193	_	_
1	33	’	’	NN	27	conj	193	194	_	_
1	34	.	.	.	6	punct	194	195	_	_

2	1	These	these	DT	7	nsubj	196	201	_	_
2	2	are	be	VBP	7	aux	202	205	_	_
2	3	not	not	RB	7	neg	206	209	_	_
2	4	always	always	RB	7	advmod	210	216	_	_
2	5	exactly	exactly	RB	7	advmod	217	224	_	_
2	6	the	the	DT	7	det	225	228	_	_
2	7	same	same	JJ	0	ROOT	229	233	_	_
2	8	as	as	IN	12	mark	234	236	_	_
2	9	‘	‘	JJ	11	amod	237	238	_	_
2	10	side	side	JJ	11	amod	238	242	_	_
2	11	effects	effect	NNS	12	nsubj	243	250	_	_
2	12	’	’	VBP	7	advcl	250	251	_	_
2	13	,	,	,	12	punct	251	252	_	_
2	14	because	because	IN	15	mark	253	260	_	_
2	15	reporting	report	VBG	12	advcl	261	270	_	_
2	16	an	a	DT	18	det	271	273	_	_
2	17	adverse	adverse	JJ	18	amod	274	281	_	_
2	18	event	event	NN	15	dobj	282	287	_	_
2	19	after	after	IN	23	mark	288	293	_	_
2	20	vaccination	vaccination	NN	23	nsubj	294	305	_	_
2	21	does	do	VBZ	23	aux	306	310	_	_
2	22	not	not	RB	23	neg	311	314	_	_
2	23	prove	prove	VB	15	advcl	315	320	_	_
2	24	a	a	DT	25	det	321	322	_	_
2	25	link	link	NN	23	dobj	323	327	_	_
2	26	with	with	IN	28	case	328	332	_	_
2	27	the	the	DT	28	det	333	336	_	_
2	28	vaccine	vaccine	NN	23	nmod	337	344	_	_
2	29	.	.	.	7	punct	344	345	_	_

3	1	When	when	WRB	5	advmod	346	350	_	_
3	2	a	a	DT	3	det	351	352	_	_
3	3	vaccine	vaccine	NN	5	nsubjpass	353	360	_	_
3	4	is	be	VBZ	5	auxpass	361	363	_	_
3	5	given	give	VBN	19	advcl	364	369	_	_
3	6	to	to	TO	10	case	370	372	_	_
3	7	a	a	DT	10	det	373	374	B-persongroup-33304	_
3	8	very	very	RB	9	advmod	375	379	I-persongroup-33304	_
3	9	large	large	JJ	10	amod	380	385	I-persongroup-33304	_
3	10	number	number	NN	5	nmod	386	392	I-persongroup-33304	_
3	11	of	of	IN	12	case	393	395	I-persongroup-33304	_
3	12	people	people	NNS	10	nmod	396	402	I-persongroup-33304	_
3	13	in	in	IN	15	case	403	405	I-persongroup-33304	_
3	14	a	a	DT	15	det	406	407	I-persongroup-33304	_
3	15	population	population	NN	12	nmod	408	418	I-persongroup-33304	_
3	16	,	,	,	19	punct	418	419	I-persongroup-33304	_
3	17	it	it	PRP	19	nsubj	420	422	_	_
3	18	is	be	VBZ	19	cop	423	425	_	_
3	19	likely	likely	JJ	0	ROOT	426	432	_	_
3	20	just	just	RB	22	advmod	433	437	_	_
3	21	by	by	IN	22	case	438	440	_	_
3	22	chance	chance	NN	19	nmod	441	447	_	_
3	23	that	that	IN	29	mark	448	452	_	_
3	24	a	a	DT	25	det	453	454	B-persongroup-33305	_
3	25	few	few	JJ	29	nsubj	455	458	I-persongroup-33305	_
3	26	of	of	IN	27	case	459	461	I-persongroup-33305	_
3	27	them	they	PRP	25	nmod	462	466	I-persongroup-33305	_
3	28	will	will	MD	29	aux	467	471	_	_
3	29	develop	develop	VB	19	ccomp	472	479	_	_
3	30	some	some	DT	31	det	480	484	_	_
3	31	kind	kind	NN	29	dobj	485	489	_	_
3	32	of	of	IN	34	case	490	492	_	_
3	33	medical	medical	JJ	34	amod	493	500	_	_
3	34	problem	problem	NN	31	nmod	501	508	_	_
3	35	around	around	IN	37	case	509	515	_	_
3	36	the	the	DT	37	det	516	519	_	_
3	37	time	time	NN	29	nmod	520	524	_	_
3	38	of	of	IN	39	case	525	527	_	_
3	39	vaccination	vaccination	NN	37	nmod	528	539	_	_
3	40	,	,	,	19	punct	539	540	_	_
3	41	but	but	CC	19	cc	541	544	_	_
3	42	this	this	DT	45	nsubj	545	549	_	_
3	43	does	do	VBZ	45	aux	550	554	_	_
3	44	not	not	RB	45	neg	555	558	_	_
3	45	prove	prove	VB	19	conj	559	564	_	_
3	46	‘	‘	NN	47	compound	565	566	_	_
3	47	cause	cause	NN	45	dobj	566	571	_	_
3	48	and	and	CC	47	cc	572	575	_	_
3	49	effect	effect	NN	50	compound	576	582	_	_
3	50	’	’	NN	47	conj	582	583	_	_
3	51	.	.	.	19	punct	583	584	_	_

4	1	This	this	DT	2	nsubj	585	589	_	_
4	2	means	mean	VBZ	0	ROOT	590	595	_	_
4	3	that	that	IN	16	mark	596	600	_	_
4	4	the	the	DT	5	det	601	604	_	_
4	5	reactions	reaction	NNS	16	nsubj	605	614	_	_
4	6	listed	list	VBN	5	acl	615	621	_	_
4	7	in	in	IN	10	case	622	624	_	_
4	8	the	the	DT	10	det	625	628	_	_
4	9	product	product	NN	10	compound	629	636	_	_
4	10	information	information	NN	6	nmod	637	648	_	_
4	11	may	may	MD	16	aux	649	652	_	_
4	12	not	not	RB	16	neg	653	656	_	_
4	13	all	all	DT	16	advmod	657	660	_	_
4	14	be	be	VB	16	cop	661	663	_	_
4	15	side	side	JJ	16	amod	664	668	_	_
4	16	effects	effect	NNS	2	ccomp	669	676	_	_
4	17	of	of	IN	19	case	677	679	_	_
4	18	the	the	DT	19	det	680	683	_	_
4	19	vaccine	vaccine	NN	16	nmod	684	691	_	_
4	20	itself	itself	PRP	19	advmod	692	698	_	_
4	21	.	.	.	2	punct	698	699	_	_

5	1	Some	some	DT	2	det	700	704	_	_
5	2	events	event	NNS	7	nsubjpass	705	711	_	_
5	3	after	after	IN	4	case	712	717	_	_
5	4	immunisation	immunisation	NN	2	nmod	718	730	_	_
5	5	are	be	VBP	7	auxpass	731	734	_	_
5	6	clearly	clearly	RB	7	advmod	735	742	_	_
5	7	caused	cause	VBN	0	ROOT	743	749	_	_
5	8	by	by	IN	11	case	750	752	_	_
5	9	the	the	DT	11	det	753	756	_	_
5	10	vaccine	vaccine	NN	11	compound	757	764	_	_
5	11	(	(	NN	7	nmod	765	766	_	_
5	12	for	for	IN	13	case	766	769	_	_
5	13	example	example	NN	11	nmod	770	777	_	_
5	14	,	,	,	13	punct	777	778	_	_
5	15	a	a	DT	17	det	779	780	_	_
5	16	sore	sore	JJ	17	amod	781	785	_	_
5	17	arm	arm	NN	13	appos	786	789	_	_
5	18	at	at	IN	21	case	790	792	_	_
5	19	the	the	DT	21	det	793	796	_	_
5	20	injection	injection	NN	21	compound	797	806	_	_
5	21	site	site	NN	17	nmod	807	811	_	_
5	22	)	)	CD	17	dep	811	812	_	_
5	23	.	.	.	7	punct	812	813	_	_

6	1	However	however	RB	5	advmod	814	821	_	_
6	2	,	,	,	5	punct	821	822	_	_
6	3	others	other	NNS	5	nsubj	823	829	_	_
6	4	may	may	MD	5	aux	830	833	_	_
6	5	happen	happen	VB	0	ROOT	834	840	_	_
6	6	by	by	IN	7	case	841	843	_	_
6	7	coincidence	coincidence	NN	5	nmod	844	855	_	_
6	8	around	around	IN	10	case	856	862	_	_
6	9	the	the	DT	10	det	863	866	_	_
6	10	time	time	NN	5	nmod	867	871	_	_
6	11	of	of	IN	12	case	872	874	_	_
6	12	vaccination	vaccination	NN	10	nmod	875	886	_	_
6	13	.	.	.	5	punct	886	887	_	_

7	1	It	it	PRP	5	nsubj	888	890	_	_
7	2	can	can	MD	5	aux	891	894	_	_
7	3	therefore	therefore	RB	5	advmod	895	904	_	_
7	4	be	be	VB	5	cop	905	907	_	_
7	5	difficult	difficult	JJ	0	ROOT	908	917	_	_
7	6	to	to	TO	7	mark	918	920	_	_
7	7	separate	separate	VB	5	xcomp	921	929	_	_
7	8	those	those	DT	7	dobj	930	935	_	_
7	9	which	which	WDT	12	nsubjpass	936	941	_	_
7	10	are	be	VBP	12	auxpass	942	945	_	_
7	11	clearly	clearly	RB	12	advmod	946	953	_	_
7	12	caused	cause	VBN	8	acl:relcl	954	960	_	_
7	13	by	by	IN	15	case	961	963	_	_
7	14	a	a	DT	15	det	964	965	_	_
7	15	vaccine	vaccine	NN	12	nmod	966	973	_	_
7	16	and	and	CC	15	cc	974	977	_	_
7	17	those	those	DT	15	conj	978	983	_	_
7	18	that	that	WDT	20	nsubj	984	988	_	_
7	19	were	be	VBD	20	aux	989	993	_	_
7	20	going	go	VBG	17	acl:relcl	994	999	_	_
7	21	to	to	TO	22	mark	1000	1002	_	_
7	22	happen	happen	VB	20	xcomp	1003	1009	_	_
7	23	anyway	anyway	RB	22	advmod	1010	1016	_	_
7	24	.	.	.	5	punct	1016	1017	_	_

8	1	In	in	IN	3	case	1018	1020	_	_
8	2	clinical	clinical	JJ	3	amod	1021	1029	_	_
8	3	trials	trial	NNS	9	nmod	1030	1036	_	_
8	4	all	all	DT	7	det	1037	1040	_	_
8	5	serious	serious	JJ	7	amod	1041	1048	_	_
8	6	adverse	adverse	JJ	7	amod	1049	1056	_	_
8	7	events	event	NNS	9	nsubjpass	1057	1063	_	_
8	8	are	be	VBP	9	auxpass	1064	1067	_	_
8	9	reported	report	VBN	0	ROOT	1068	1076	_	_
8	10	so	so	IN	20	mark	1077	1079	_	_
8	11	that	that	IN	10	mwe	1080	1084	_	_
8	12	unexpected	unexpected	JJ	13	amod	1085	1095	_	_
8	13	reactions	reaction	NNS	20	nsubjpass	1096	1105	_	_
8	14	to	to	TO	15	case	1106	1108	_	_
8	15	medicines	medicine	NNS	13	nmod	1109	1118	_	_
8	16	or	or	CC	15	cc	1119	1121	_	_
8	17	vaccines	vaccine	NNS	15	conj	1122	1130	_	_
8	18	can	can	MD	20	aux	1131	1134	_	_
8	19	be	be	VB	20	auxpass	1135	1137	_	_
8	20	identified	identify	VBN	9	advcl	1138	1148	_	_
8	21	.	.	.	9	punct	1148	1149	_	_

9	1	This	this	DT	4	nsubj	1150	1154	_	_
9	2	is	be	VBZ	4	cop	1155	1157	_	_
9	3	very	very	RB	4	advmod	1158	1162	_	_
9	4	important	important	JJ	0	ROOT	1163	1172	_	_
9	5	for	for	IN	7	case	1173	1176	_	_
9	6	safety	safety	NN	7	compound	1177	1183	_	_
9	7	monitoring	monitoring	NN	4	nmod	1184	1194	_	_
9	8	,	,	,	4	punct	1194	1195	_	_
9	9	but	but	CC	4	cc	1196	1199	_	_
9	10	it	it	PRP	12	nsubj	1200	1202	_	_
9	11	also	also	RB	12	advmod	1203	1207	_	_
9	12	means	mean	VBZ	4	conj	1208	1213	_	_
9	13	that	that	IN	20	mark	1214	1218	_	_
9	14	extreme	extreme	JJ	15	amod	1219	1226	_	_
9	15	examples	example	NNS	20	nsubj	1227	1235	_	_
9	16	of	of	IN	19	case	1236	1238	_	_
9	17	‘	‘	CD	19	nummod	1239	1240	_	_
9	18	adverse	adverse	JJ	19	amod	1240	1247	_	_
9	19	events	event	NNS	15	nmod	1248	1254	_	_
9	20	’	’	VBP	12	ccomp	1254	1255	_	_
9	21	may	may	MD	23	aux	1256	1259	_	_
9	22	get	get	VB	23	auxpass	1260	1263	_	_
9	23	listed	list	VBN	20	ccomp	1264	1270	_	_
9	24	when	when	WRB	26	advmod	1271	1275	_	_
9	25	they	they	PRP	26	nsubj	1276	1280	_	_
9	26	have	have	VBP	23	advcl	1281	1285	_	_
9	27	no	no	DT	28	neg	1286	1288	_	_
9	28	connection	connection	NN	26	dobj	1289	1299	_	_
9	29	to	to	TO	31	case	1300	1302	_	_
9	30	the	the	DT	31	det	1303	1306	_	_
9	31	vaccine	vaccine	NN	28	nmod	1307	1314	_	_
9	32	(	(	CD	36	nsubj	1315	1316	_	_
9	33	such	such	JJ	35	case	1316	1320	_	_
9	34	as	as	IN	33	mwe	1321	1323	_	_
9	35	injuries	injury	NNS	32	nmod	1324	1332	_	_
9	36	caused	cause	VBD	31	acl:relcl	1333	1339	_	_
9	37	to	to	TO	39	case	1340	1342	_	_
9	38	a	a	DT	39	det	1343	1344	B-persongroup-33306	_
9	39	passenger	passenger	NN	36	nmod	1345	1354	I-persongroup-33306	_
9	40	in	in	IN	43	case	1355	1357	_	_
9	41	a	a	DT	43	det	1358	1359	_	_
9	42	car	car	NN	43	compound	1360	1363	_	_
9	43	accident	accident	NN	36	nmod	1364	1372	_	_
9	44	,	,	,	43	punct	1372	1373	_	_
9	45	which	which	WDT	49	nsubj	1374	1379	_	_
9	46	are	be	VBP	49	aux	1380	1383	_	_
9	47	clearly	clearly	RB	49	advmod	1384	1391	_	_
9	48	not	not	RB	49	neg	1392	1395	_	_
9	49	related	related	JJ	43	acl:relcl	1396	1403	_	_
9	50	to	to	TO	52	case	1404	1406	_	_
9	51	any	any	DT	52	det	1407	1410	_	_
9	52	vaccine	vaccine	NN	49	nmod	1411	1418	_	_
9	53	they	they	PRP	56	nsubj	1419	1423	B-persongroup-33319	_
9	54	may	may	MD	56	aux	1424	1427	_	_
9	55	have	have	VB	56	aux	1428	1432	_	_
9	56	received	receive	VBN	52	acl:relcl	1433	1441	_	_
9	57	)	)	CD	56	dobj	1441	1442	_	_
9	58	.	.	.	4	punct	1442	1443	_	_

10	1	Also	also	RB	14	advmod	1444	1448	_	_
10	2	events	event	NNS	14	nsubjpass	1449	1455	_	_
10	3	such	such	JJ	5	mark	1456	1460	_	_
10	4	as	as	IN	3	mwe	1461	1463	_	_
10	5	fainting	faint	VBG	2	acl	1464	1472	_	_
10	6	at	at	IN	8	case	1473	1475	_	_
10	7	the	the	DT	8	det	1476	1479	_	_
10	8	sight	sight	NN	5	nmod	1480	1485	_	_
10	9	of	of	IN	11	case	1486	1488	_	_
10	10	a	a	DT	11	det	1489	1490	_	_
10	11	needle	needle	NN	8	nmod	1491	1497	_	_
10	12	may	may	MD	14	aux	1498	1501	_	_
10	13	be	be	VB	14	auxpass	1502	1504	_	_
10	14	called	call	VBN	0	ROOT	1505	1511	_	_
10	15	an	a	DT	17	det	1512	1514	_	_
10	16	adverse	adverse	JJ	17	amod	1515	1522	_	_
10	17	event	event	NN	14	dobj	1523	1528	_	_
10	18	,	,	,	14	punct	1528	1529	_	_
10	19	even	even	RB	26	advmod	1530	1534	_	_
10	20	though	though	IN	26	mark	1535	1541	_	_
10	21	the	the	DT	22	det	1542	1545	B-persongroup-33307	_
10	22	person	person	NN	26	nsubj	1546	1552	I-persongroup-33307	_
10	23	has	have	VBZ	26	aux	1553	1556	_	_
10	24	not	not	RB	26	neg	1557	1560	_	_
10	25	actually	actually	RB	26	advmod	1561	1569	_	_
10	26	received	receive	VBD	14	advcl	1570	1578	_	_
10	27	the	the	DT	28	det	1579	1582	_	_
10	28	vaccine	vaccine	NN	26	dobj	1583	1590	_	_
10	29	.	.	.	14	punct	1590	1591	_	_

11	1	However	however	RB	4	advmod	1592	1599	_	_
11	2	,	,	,	4	punct	1599	1600	_	_
11	3	experts	expert	NNS	4	nsubj	1601	1608	B-persongroup-33308	_
11	4	consider	consider	VBP	0	ROOT	1609	1617	_	_
11	5	it	it	PRP	6	nsubj	1618	1620	_	_
11	6	important	important	JJ	4	xcomp	1621	1630	_	_
11	7	that	that	IN	13	mark	1631	1635	_	_
11	8	every	every	DT	11	det	1636	1641	_	_
11	9	single	single	JJ	11	amod	1642	1648	_	_
11	10	adverse	adverse	JJ	11	amod	1649	1656	_	_
11	11	event	event	NN	13	nsubjpass	1657	1662	_	_
11	12	is	be	VBZ	13	auxpass	1663	1665	_	_
11	13	collected	collect	VBN	6	ccomp	1666	1675	_	_
11	14	and	and	CC	13	cc	1676	1679	_	_
11	15	reported	report	VBN	13	conj	1680	1688	_	_
11	16	,	,	,	4	punct	1688	1689	_	_
11	17	so	so	IN	21	mark	1690	1692	_	_
11	18	that	that	IN	17	mwe	1693	1697	_	_
11	19	we	we	PRP	21	nsubj	1698	1700	B-persongroup-33309	_
11	20	can	can	MD	21	aux	1701	1704	_	_
11	21	identify	identify	VB	4	advcl	1705	1713	_	_
11	22	any	any	DT	25	det	1714	1717	_	_
11	23	‘	‘	NN	25	compound	1718	1719	_	_
11	24	signal	signal	NN	25	compound	1719	1725	_	_
11	25	’	’	NN	21	dobj	1725	1726	_	_
11	26	of	of	IN	30	case	1727	1729	_	_
11	27	a	a	DT	30	det	1730	1731	_	_
11	28	possible	possible	JJ	30	amod	1732	1740	_	_
11	29	vaccine-caused	vaccine-caused	JJ	30	amod	1741	1755	_	_
11	30	harm	harm	NN	25	nmod	1756	1760	_	_
11	31	amongst	amongst	IN	35	case	1761	1768	_	_
11	32	all	all	PDT	35	det:predet	1769	1772	_	_
11	33	the	the	DT	35	det	1773	1776	_	_
11	34	chance	chance	NN	35	compound	1777	1783	_	_
11	35	events	event	NNS	21	nmod	1784	1790	_	_
11	36	that	that	WDT	37	nsubj	1791	1795	_	_
11	37	happen	happen	VBP	35	acl:relcl	1796	1802	_	_
11	38	to	to	TO	39	case	1803	1805	_	_
11	39	people	people	NNS	37	nmod	1806	1812	B-persongroup-33310	_
11	40	every	every	DT	41	det	1813	1818	_	_
11	41	day	day	NN	39	dep	1819	1822	_	_
11	42	.	.	.	4	punct	1822	1823	_	_

12	1	In	in	IN	3	case	1824	1826	_	_
12	2	the	the	DT	3	det	1827	1830	B-persongroup-33311	_
12	3	UK	UK	NNP	7	nmod	1831	1833	I-persongroup-33311	_
12	4	it	it	PRP	7	nsubj	1834	1836	_	_
12	5	is	be	VBZ	7	cop	1837	1839	_	_
12	6	the	the	DT	7	det	1840	1843	_	_
12	7	job	job	NN	0	ROOT	1844	1847	_	_
12	8	of	of	IN	10	case	1848	1850	_	_
12	9	the	the	DT	10	det	1851	1854	B-persongroup-33312	_
12	10	MHRA	MHRA	NNP	7	nmod	1855	1859	I-persongroup-33312	_
12	11	to	to	TO	12	mark	1860	1862	_	_
12	12	collect	collect	VB	7	acl	1863	1870	_	_
12	13	all	all	PDT	15	det:predet	1871	1874	_	_
12	14	these	these	DT	15	det	1875	1880	_	_
12	15	reports	report	NNS	12	dobj	1881	1888	_	_
12	16	and	and	CC	12	cc	1889	1892	_	_
12	17	investigate	investigate	VB	12	conj	1893	1904	_	_
12	18	further	further	RB	17	advmod	1905	1912	_	_
12	19	if	if	IN	22	mark	1913	1915	_	_
12	20	necessary	necessary	JJ	21	amod	1916	1925	_	_
12	21	(	(	NN	22	nsubj	1926	1927	_	_
12	22	see	see	VB	17	advcl	1927	1930	_	_
12	23	more	more	JJR	24	amod	1931	1935	_	_
12	24	information	information	NN	22	dobj	1936	1947	_	_
12	25	on	on	IN	26	case	1948	1950	_	_
12	26	Monitoring	monitoring	NN	22	nmod	1951	1961	_	_
12	27	of	of	IN	28	case	1962	1964	_	_
12	28	vaccines	vaccine	NNS	26	nmod	1965	1973	_	_
12	29	)	)	CD	12	dobj	1973	1974	_	_
12	30	.	.	.	7	punct	1974	1975	_	_

13	1	Scientific	Scientific	NNP	2	compound	1976	1986	_	_
13	2	method	method	NN	5	nsubjpass	1987	1993	_	_
13	3	is	be	VBZ	5	auxpass	1994	1996	_	_
13	4	then	then	RB	5	advmod	1997	2001	_	_
13	5	used	use	VBN	0	ROOT	2002	2006	_	_
13	6	to	to	TO	7	mark	2007	2009	_	_
13	7	determine	determine	VB	5	xcomp	2010	2019	_	_
13	8	if	if	IN	13	mark	2020	2022	_	_
13	9	these	these	DT	10	det	2023	2028	_	_
13	10	events	event	NNS	13	nsubj	2029	2035	_	_
13	11	are	be	VBP	13	cop	2036	2039	_	_
13	12	a	a	DT	13	det	2040	2041	_	_
13	13	coincidence	coincidence	NN	7	advcl	2042	2053	_	_
13	14	or	or	CC	13	cc	2054	2056	_	_
13	15	a	a	DT	16	det	2057	2058	_	_
13	16	result	result	NN	13	conj	2059	2065	_	_
13	17	of	of	IN	19	case	2066	2068	_	_
13	18	the	the	DT	19	det	2069	2072	_	_
13	19	vaccine	vaccine	NN	16	nmod	2073	2080	_	_
13	20	.	.	.	5	punct	2080	2081	_	_

14	1	Here	here	RB	4	advmod	2082	2086	_	_
14	2	are	be	VBP	4	dep	2087	2090	_	_
14	3	two	two	CD	4	nummod	2091	2094	_	_
14	4	examples	example	NNS	0	ROOT	2095	2103	_	_
14	5	of	of	IN	15	mark	2104	2106	_	_
14	6	how	how	WRB	15	advmod	2107	2110	_	_
14	7	collecting	collect	VBG	15	csubj	2111	2121	_	_
14	8	and	and	CC	7	cc	2122	2125	_	_
14	9	analysing	analyse	VBG	7	conj	2126	2135	_	_
14	10	data	datum	NNS	7	dobj	2136	2140	_	_
14	11	on	on	IN	13	case	2141	2143	_	_
14	12	adverse	adverse	JJ	13	amod	2144	2151	_	_
14	13	events	event	NNS	7	nmod	2152	2158	_	_
14	14	has	have	VBZ	15	aux	2159	2162	_	_
14	15	helped	help	VBN	4	acl	2163	2169	_	_
14	16	us	we	PRP	15	dobj	2170	2172	B-persongroup-33313	_
14	17	to	to	TO	18	mark	2173	2175	_	_
14	18	understand	understand	VB	15	xcomp	2176	2186	_	_
14	19	more	more	JJR	18	dobj	2187	2191	_	_
14	20	about	about	IN	22	case	2192	2197	_	_
14	21	the	the	DT	22	det	2198	2201	_	_
14	22	safety	safety	NN	18	nmod	2202	2208	_	_
14	23	of	of	IN	24	case	2209	2211	_	_
14	24	vaccines	vaccine	NNS	22	nmod	2212	2220	_	_
14	25	.	.	.	4	punct	2220	2221	_	_

15	1	Some	some	DT	2	det	2222	2226	_	_
15	2	studies	study	NNS	7	nsubj	2227	2234	_	_
15	3	on	on	IN	6	case	2235	2237	_	_
15	4	the	the	DT	6	det	2238	2241	_	_
15	5	rotavirus	rotavirus	NN	6	compound	2242	2251	_	_
15	6	vaccine	vaccine	NN	2	nmod	2252	2259	_	_
15	7	identified	identify	VBD	0	ROOT	2260	2270	_	_
15	8	that	that	IN	10	mark	2271	2275	_	_
15	9	there	there	EX	10	expl	2276	2281	_	_
15	10	was	be	VBD	7	ccomp	2282	2285	_	_
15	11	possibly	possibly	RB	10	advmod	2286	2294	_	_
15	12	a	a	DT	16	det	2295	2296	_	_
15	13	very	very	RB	14	advmod	2297	2301	_	_
15	14	slightly	slightly	RB	16	amod	2302	2310	_	_
15	15	increased	increase	VBN	16	amod	2311	2320	_	_
15	16	risk	risk	NN	10	nsubj	2321	2325	_	_
15	17	of	of	IN	20	case	2326	2328	_	_
15	18	a	a	DT	20	det	2329	2330	_	_
15	19	rare	rare	JJ	20	amod	2331	2335	_	_
15	20	condition	condition	NN	16	nmod	2336	2345	_	_
15	21	called	call	VBN	20	acl	2346	2352	_	_
15	22	intussusception	intussusception	NN	21	dobj	2353	2368	_	_
15	23	following	follow	VBG	24	case	2369	2378	_	_
15	24	vaccination	vaccination	NN	22	nmod	2379	2390	_	_
15	25	.	.	.	7	punct	2390	2391	_	_

16	1	This	this	DT	3	nsubjpass	2392	2396	_	_
16	2	was	be	VBD	3	auxpass	2397	2400	_	_
16	3	discovered	discover	VBN	0	ROOT	2401	2411	_	_
16	4	by	by	IN	5	mark	2412	2414	_	_
16	5	comparing	compare	VBG	3	advcl	2415	2424	_	_
16	6	rates	rate	NNS	5	dobj	2425	2430	_	_
16	7	of	of	IN	8	case	2431	2433	_	_
16	8	intussusception	intussusception	NN	6	nmod	2434	2449	_	_
16	9	in	in	IN	12	case	2450	2452	_	_
16	10	a	a	DT	12	det	2453	2454	B-persongroup-33314	_
16	11	large	large	JJ	12	amod	2455	2460	I-persongroup-33314	_
16	12	group	group	NN	5	nmod	2461	2466	I-persongroup-33314	_
16	13	of	of	IN	14	case	2467	2469	I-persongroup-33314	_
16	14	babies	baby	NNS	12	nmod	2470	2476	I-persongroup-33314	_
16	15	who	who	WP	17	nsubj	2477	2480	_	_
16	16	had	have	VBD	17	aux	2481	2484	_	_
16	17	received	receive	VBN	14	acl:relcl	2485	2493	_	_
16	18	the	the	DT	20	det	2494	2497	_	_
16	19	rotavirus	rotavirus	NN	20	compound	2498	2507	_	_
16	20	vaccine	vaccine	NN	17	dobj	2508	2515	_	_
16	21	with	with	IN	22	case	2516	2520	_	_
16	22	rates	rate	NNS	17	nmod	2521	2526	_	_
16	23	in	in	IN	26	case	2527	2529	_	_
16	24	a	a	DT	26	det	2530	2531	B-persongroup-33315	_
16	25	large	large	JJ	26	amod	2532	2537	I-persongroup-33315	_
16	26	group	group	NN	22	nmod	2538	2543	I-persongroup-33315	_
16	27	of	of	IN	28	case	2544	2546	I-persongroup-33315	_
16	28	babies	baby	NNS	26	nmod	2547	2553	I-persongroup-33315	_
16	29	who	who	WP	32	nsubj	2554	2557	_	_
16	30	had	have	VBD	32	aux	2558	2561	_	_
16	31	not	not	RB	32	neg	2562	2565	_	_
16	32	received	receive	VBN	28	acl:relcl	2566	2574	_	_
16	33	the	the	DT	34	det	2575	2578	_	_
16	34	vaccine	vaccine	NN	32	dobj	2579	2586	_	_
16	35	.	.	.	3	punct	2586	2587	_	_

17	1	It	it	PRP	2	nsubj	2588	2590	_	_
17	2	led	lead	VBD	0	ROOT	2591	2594	_	_
17	3	to	to	TO	5	case	2595	2597	_	_
17	4	a	a	DT	5	det	2598	2599	_	_
17	5	change	change	NN	2	nmod	2600	2606	_	_
17	6	in	in	IN	8	case	2607	2609	_	_
17	7	the	the	DT	8	det	2610	2613	_	_
17	8	information	information	NN	5	nmod	2614	2625	_	_
17	9	in	in	IN	12	case	2626	2628	_	_
17	10	the	the	DT	12	det	2629	2632	_	_
17	11	product	product	NN	12	compound	2633	2640	_	_
17	12	leaflet	leaflet	NN	8	nmod	2641	2648	_	_
17	13	,	,	,	5	punct	2648	2649	_	_
17	14	and	and	CC	5	cc	2650	2653	_	_
17	15	also	also	RB	18	advmod	2654	2658	_	_
17	16	to	to	TO	18	case	2659	2661	_	_
17	17	a	a	DT	18	det	2662	2663	_	_
17	18	change	change	NN	5	conj	2664	2670	_	_
17	19	in	in	IN	20	case	2671	2673	_	_
17	20	advice	advice	NN	18	nmod	2674	2680	_	_
17	21	about	about	IN	27	mark	2681	2686	_	_
17	22	when	when	WRB	27	advmod	2687	2691	_	_
17	23	the	the	DT	24	det	2692	2695	_	_
17	24	vaccine	vaccine	NN	27	nsubjpass	2696	2703	_	_
17	25	should	should	MD	27	aux	2704	2710	_	_
17	26	be	be	VB	27	auxpass	2711	2713	_	_
17	27	given	give	VBN	2	advcl	2714	2719	_	_
17	28	(	(	CD	27	dobj	2720	2721	_	_
17	29	see	see	VBP	28	acl:relcl	2721	2724	_	_
17	30	the	the	DT	31	det	2725	2728	_	_
17	31	page	page	NN	29	dobj	2729	2733	_	_
17	32	on	on	IN	35	case	2734	2736	_	_
17	33	the	the	DT	35	det	2737	2740	_	_
17	34	Rotavirus	Rotavirus	NNP	35	compound	2741	2750	_	_
17	35	vaccine	vaccine	NN	31	nmod	2751	2758	_	_
17	36	for	for	IN	38	case	2759	2762	_	_
17	37	more	more	JJR	38	amod	2763	2767	_	_
17	38	information	information	NN	29	nmod	2768	2779	_	_
17	39	about	about	IN	42	case	2780	2785	_	_
17	40	this	this	DT	42	det	2786	2790	_	_
17	41	research	research	NN	42	compound	2791	2799	_	_
17	42	)	)	NN	38	nmod	2799	2800	_	_
17	43	.	.	.	2	punct	2800	2801	_	_

18	1	A	a	DT	3	det	2802	2803	_	_
18	2	large	large	JJ	3	amod	2804	2809	_	_
18	3	number	number	NN	11	nsubj	2810	2816	_	_
18	4	of	of	IN	5	case	2817	2819	_	_
18	5	studies	study	NNS	3	nmod	2820	2827	_	_
18	6	on	on	IN	9	case	2828	2830	_	_
18	7	the	the	DT	9	det	2831	2834	_	_
18	8	MMR	mmr	NN	9	compound	2835	2838	_	_
18	9	vaccine	vaccine	NN	5	nmod	2839	2846	_	_
18	10	have	have	VBP	11	aux	2847	2851	_	_
18	11	found	find	VBN	0	ROOT	2852	2857	_	_
18	12	no	no	DT	14	neg	2858	2860	_	_
18	13	increased	increase	VBN	14	amod	2861	2870	_	_
18	14	risk	risk	NN	11	dobj	2871	2875	_	_
18	15	of	of	IN	16	case	2876	2878	_	_
18	16	autism	autism	NN	14	nmod	2879	2885	_	_
18	17	in	in	IN	20	case	2886	2888	_	_
18	18	very	very	RB	19	advmod	2889	2893	B-persongroup-33316	_
18	19	large	large	JJ	20	amod	2894	2899	I-persongroup-33316	_
18	20	groups	group	NNS	16	nmod	2900	2906	I-persongroup-33316	_
18	21	of	of	IN	22	case	2907	2909	I-persongroup-33316	_
18	22	children	child	NNS	20	nmod	2910	2918	I-persongroup-33316	_
18	23	who	who	WP	25	nsubj	2919	2922	_	_
18	24	have	have	VBP	25	aux	2923	2927	_	_
18	25	received	receive	VBN	14	acl:relcl	2928	2936	_	_
18	26	the	the	DT	27	det	2937	2940	_	_
18	27	vaccine	vaccine	NN	25	dobj	2941	2948	_	_
18	28	.	.	.	11	punct	2948	2949	_	_

19	1	Again	again	RB	6	advmod	2950	2955	_	_
19	2	,	,	,	6	punct	2955	2956	_	_
19	3	this	this	DT	6	nsubjpass	2957	2961	_	_
19	4	has	have	VBZ	6	aux	2962	2965	_	_
19	5	been	be	VBN	6	auxpass	2966	2970	_	_
19	6	done	do	VBN	0	ROOT	2971	2975	_	_
19	7	by	by	IN	8	mark	2976	2978	_	_
19	8	comparing	compare	VBG	6	advcl	2979	2988	_	_
19	9	rates	rate	NNS	8	dobj	2989	2994	_	_
19	10	of	of	IN	11	case	2995	2997	_	_
19	11	autism	autism	NN	9	nmod	2998	3004	_	_
19	12	in	in	IN	14	case	3005	3007	_	_
19	13	large	large	JJ	14	amod	3008	3013	B-persongroup-33317	_
19	14	groups	group	NNS	8	nmod	3014	3020	I-persongroup-33317	_
19	15	of	of	IN	16	case	3021	3023	I-persongroup-33317	_
19	16	children	child	NNS	14	nmod	3024	3032	I-persongroup-33317	_
19	17	who	who	WP	19	nsubj	3033	3036	_	_
19	18	have	have	VBP	19	aux	3037	3041	_	_
19	19	received	receive	VBN	16	acl:relcl	3042	3050	_	_
19	20	the	the	DT	22	det	3051	3054	_	_
19	21	MMR	mmr	NN	22	compound	3055	3058	_	_
19	22	vaccine	vaccine	NN	19	dobj	3059	3066	_	_
19	23	with	with	IN	25	case	3067	3071	_	_
19	24	large	large	JJ	25	amod	3072	3077	B-persongroup-33318	_
19	25	groups	group	NNS	19	nmod	3078	3084	I-persongroup-33318	_
19	26	who	who	WP	29	nsubj	3085	3088	I-persongroup-33318	_
19	27	have	have	VBP	29	aux	3089	3093	I-persongroup-33318	_
19	28	not	not	RB	29	neg	3094	3097	I-persongroup-33318	_
19	29	(	(	VB	25	acl:relcl	3098	3099	_	_
19	30	see	see	VB	29	xcomp	3099	3102	_	_
19	31	the	the	DT	32	det	3103	3106	_	_
19	32	page	page	NN	30	dobj	3107	3111	_	_
19	33	on	on	IN	36	case	3112	3114	_	_
19	34	the	the	DT	36	det	3115	3118	_	_
19	35	MMR	mmr	NN	36	compound	3119	3122	_	_
19	36	vaccine	vaccine	NN	30	nmod	3123	3130	_	_
19	37	for	for	IN	39	case	3131	3134	_	_
19	38	more	more	JJR	39	amod	3135	3139	_	_
19	39	information	information	NN	36	nmod	3140	3151	_	_
19	40	about	about	IN	43	case	3152	3157	_	_
19	41	this	this	DT	43	det	3158	3162	_	_
19	42	research	research	NN	43	compound	3163	3171	_	_
19	43	)	)	NN	39	nmod	3171	3172	_	_
19	44	.	.	.	6	punct	3172	3173	_	_

20	1	For	for	IN	2	case	3174	3177	_	_
20	2	information	information	NN	11	nmod	3178	3189	_	_
20	3	on	on	IN	5	case	3190	3192	_	_
20	4	side	side	JJ	5	amod	3193	3197	_	_
20	5	effects	effect	NNS	2	nmod	3198	3205	_	_
20	6	of	of	IN	8	case	3206	3208	_	_
20	7	individual	individual	JJ	8	amod	3209	3219	_	_
20	8	vaccines	vaccine	NNS	5	nmod	3220	3228	_	_
20	9	,	,	,	11	punct	3228	3229	_	_
20	10	please	please	VB	11	discourse	3230	3236	_	_
20	11	see	see	VB	0	ROOT	3237	3240	_	_
20	12	the	the	DT	13	det	3241	3244	_	_
20	13	pages	page	NNS	11	dobj	3245	3250	_	_
20	14	on	on	IN	15	case	3251	3253	_	_
20	15	vaccines	vaccine	NNS	13	nmod	3254	3262	_	_
20	16	under	under	IN	18	case	3263	3268	_	_
20	17	'	'	''	18	punct	3269	3270	_	_
20	18	Information	information	NN	11	nmod	3270	3281	_	_
20	19	on	on	IN	20	case	3282	3284	_	_
20	20	vaccines	vaccine	NNS	18	nmod	3285	3293	_	_
20	21	'	'	POS	20	case	3293	3294	_	_
20	22	.	.	.	11	punct	3294	3295	_	_
